Source: http://grants2.nih.gov/grants/guide/pa-files/PA-06-119.html
Timestamp: 2014-10-30 14:30:53
Document Index: 780645360

Matched Legal Cases: ['art6', 'art7', 'art4', 'art4', 'art9', 'arts 74']

Department of Health and Human Services Participating Organizations National Institutes of Health (NIH), (http://www.nih.gov) Components of Participating Organizations National Institute on Aging (NIA), (http://www.nia.nih.gov/) National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), (http://www.niams.nih.gov/) National Cancer Institute (NCI), (http://www.nci.nih.gov) National Institute on Deafness and Other Communication Disorders (NIDCD), (http://www.nidcd.nih.gov/) National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), (http://www.niddk.nih.gov/) National Institute of Environmental Health Sciences (NIEHS), (http://www.niehs.nih.gov) National Institute of General Medical Sciences (NIGMS), (http://www.nigms.nih.gov) National Heart, Lung, and Blood Institute (NHLBI), (http://www.nhlbi.nih.gov) National Institute of Mental Health (NIMH), (http://www.nimh.nih.gov/) National Institute of Neurological Disorders and Stroke (NINDS), (http://www.ninds.nih.gov/) Title: Structural Biology of Membrane Proteins (R01) Announcement Type This is a reissue of PA-02-060, which was previously released February 11, 2002. Update: The following update relating to this announcement has been issued:
December 20, 2006 - The R01 portion of this funding opportunity has been replaced by PA-07-253, which now uses the electronic SF424 (R&R) application for February 5, 2007 submission dates and beyond.
Looking ahead: As part of the Department of Health and Human Services' implementation of e-Government, during FY 2006 the NIH will gradually transition each research grant mechanism to electronic submission through Grants.gov and the use of the SF 424 Research and Related (R&R) forms. Therefore, once the transition is made for a specific grant mechanism, investigators and institutions will be required to submit applications electronically using Grants.gov.. For more information and an initial timeline, see http://era.nih.gov/ElectronicReceipt/. NIH will announce each grant mechanism change in the NIH Guide to Grants and Contracts (http://grants.nih.gov/grants/guide/index.html). Specific funding opportunity announcements will also clearly indicate if Grants.gov submission and the use of the SF424 (R&R) is required. Investigators should consult the NIH Forms and Applications Web site (http://grants.nih.gov/grants/forms.htm) for the most current information when preparing a grant application. Program Announcement (PA) Number: PA-06-119 Catalog of Federal Domestic Assistance Number(s) 93.866, 93.846, 93.396, 93.173, 93.847, 93.113, 93.859, 93.837, 93.242, 93.853 Key Dates Release Date: January 20, 2006 Letters of Intent Receipt Date(s): Not applicable. Application Receipt Dates(s): Standard dates apply, please see
http://grants.nih.gov/grants/funding/submissionschedule.htm Peer Review Date(s): Standard dates apply; please see http://grants.nih.gov/grants/funding/submissionschedule.htm#reviewandaward for guidance on dates. Council Review Date(s): Standard dates apply; please see http://grants.nih.gov/grants/funding/submissionschedule.htm#reviewandaward for guidance on dates. Earliest Anticipated Start Date: Standard dates apply; please see http://grants.nih.gov/grants/funding/submissionschedule.htm#reviewandaward for guidance on dates. Expiration Date for R01 Non-AIDS Applications: November 2, 2006 Expiration Date for R01 AIDS and AIDS-Related Applications: January 3, 2007
Due Dates for E.O. 12372 Not Applicable Additional Overview Content Executive Summary This PA solicits applications to develop research and methods to enhance the rate of membrane protein structure determination and to determine specific membrane protein structures. Innovative methods for expression, oligomerization, solubilization, stabilization, purification, characterization, crystallization, isotopic labeling, and structure determination of unique and biologically significant membrane proteins by x-ray diffraction, nuclear magnetic resonance (NMR), electron microscopic, mass spectrometry, and other biophysical techniques are encouraged. Projects that will lead in the near term to determining the structures of biologically important membrane proteins are also encouraged. Because the nature and scope of the proposed research will vary from application to application, it is anticipated that the size and duration of each award will also vary. The total amount awarded and the number of awards will depend upon the quality, duration, and costs of the applications received. This PA will use the NIH individual research project grant (R01) award mechanism. Eligible organizations include for-profit or non-profit organizations; public or private institutions, such as universities, colleges, hospitals, and laboratories; units or State and local government; eligible agencies of the Federal government; domestic or foreign institutions; and, faith-based or community based organizations. Eligible principal investigators include any individual with the skills, knowledge, and resources necessary to carry out the proposed research. Individuals from underrepresented racial and ethnic groups as well as individuals with disabilities are always encouraged to apply for NIH programs. Applicants may submit more than one application, provided they are scientifically distinct. See Section IV.1 for application materials. Telecommunications for the hearing impaired is available at: TTY 301-451-5936 Table of Contents Part I Overview Information Part II Full Text of Announcement Section I. Funding Opportunity Description 1. Research Objectives Section II. Award Information 1. Mechanism(s) of Support 2. Funds Available Section III. Eligibility Information 1. Eligible Applicants A. Eligible Institutions B. Eligible Individuals 2.Cost Sharing or Matching 3. Other - Special Eligibility Criteria Section IV. Application and Submission Information 1. Address to Request Application Information 2. Content and Form of Application Submission 3. Submission Dates and Times A. Receipt and Review and Anticipated Start Dates 1. Letter of Intent B. Sending an Application to the NIH C. Application Processing 4. Intergovernmental Review 5. Funding Restrictions 6. Other Submission Requirements Section V. Application Review Information 1. Criteria 2. Review and Selection Process A. Additional Review Criteria B. Additional Review Considerations C. Sharing Research Data D. Sharing Research Resources 3. Anticipated Announcement and Award Dates Section VI. Award Administration Information 1. Award Notices 2. Administrative and National Policy Requirements 3. Reporting Section VII. Agency Contact(s) 1. Scientific/Research Contact(s) 2. Peer Review Contact(s) 3. Financial/ Grants Management Contact(s) Section VIII. Other Information - Required Federal Citations Part II - Full Text of Announcement
Section I. Funding Opportunity Description 1. Research Objectives The purpose of this Program Announcement (PA) is to encourage applications for research that will lead to the determination of membrane protein structures at high resolution. In addition to the structures of integral membrane proteins, the structures of the complexes formed between these proteins and their biological partners are of interest. Despite increases in the number of solved structures, the knowledge of membrane protein structures still lags far behind that of soluble proteins. Applications are sought both for the development of new methods to approach the problem and for the application of current methods to the solution of specific membrane protein structures. Areas of interest include innovative methods for production of membrane proteins in sufficient quantities for characterization and structural studies of membrane proteins. Novel approaches to cloning, expression, oligomeric assembly, solubilization, stabilization and purification of membrane proteins are needed to advance the production of structurally and functionally intact membrane proteins suitable for structural studies. Innovative methods are also needed for structure determination, including crystallization, phasing, isotopic labeling, and collecting x-ray crystallographic, nuclear magnetic resonance (NMR), and other relevant data. It is recognized that novel solutions may arise during the course of efforts to solve the structures of specific membrane proteins as well as through focused efforts stressing methods development. Investigators with different perspectives and backgrounds and with significant interests in the determination of membrane protein structures are particularly encouraged to apply. Background: Membrane proteins and their complexes play crucial roles in many cellular and physiological processes. They are essential mediators of material, information, and energy transfer between cells and their environment, between compartments within cells, and between compartments comprising the organ systems. Functionally normal membrane proteins are vital to health, and specific defects are associated with many known disease states. Membrane proteins are the targets of a large number of pharmacologically and toxicologically active substances and are responsible, in part, for their uptake, metabolism, and clearance. Considerable research is ongoing in the area of membrane protein structure and function, yet relatively few investigators have successfully applied the techniques of x-ray crystallography, electron diffraction, or NMR spectroscopy to solve the high resolution structures of their proteins. During the past decade, approximately 100 unique membrane protein structures have been solved, and each structure has made a major contribution in its area of science. (see http://blanco.biomol.uci.edu/Membrane_Proteins_xtal.html and/or http://www.mpibp-frankfurt.mpg.de/michel/public/memprotstruct.html ) However, during this same decade the rate of soluble protein structure determination has accelerated greatly, and there remains a huge gap between the understanding of membrane proteins and their soluble protein counterparts (1). The much slower progress demonstrates that solving membrane protein structures is feasible albeit difficult, so innovative approaches are clearly still needed. This announcement continues NIH efforts to stimulate work on membrane protein structures. Responses to previous program announcements in this area have resulted in over 103 competing awards over the period FY1995-FY2005 (2). In 2004, through the NIH Roadmap, two Centers for Innovation in Membrane Protein Production were awarded (3). A second NIH Roadmap effort focused on individual researchers and smaller collaborative groups. In 2005, a total of 18, R01 and R21 grants, as well as one program project grant, were awarded through the NIH Roadmap (4) for the development of innovative methods for membrane protein production and structure determination. A significant number of meritorious applications received in response to the Roadmap RFAs could not be funded due to the limited amount of money available. Other applications were not competitive in the context of those RFAs because they focused on the solution of specific protein structures instead of the development of new methods. Such projects may be appropriate and responsive to the current program announcement Investigators who submitted applications for these RFAs may wish to rework their ideas into a new application in response to this PA. Any projects that were previously submitted in response to the Roadmap RFAs should be submitted as NEW, rather than REVISED, applications by the appropriate submission dates. See NIH Policy at: http://grants.nih.gov/grants/guide/notice-files/NOT-OD-03-019.html It is expected that some of the projects will be collaborative efforts between and among chemists, biochemists, molecular biologists, and biophysicists with expertise in the synthesis of probes, novel solubilizing and stabilizing reagents; in cloning and expression; in the isolation and characterization of membrane-bound proteins; and in x-ray crystallography, NMR, and other structural methods. An objective of this PA is to stimulate such multidisciplinary and new collaborations. A further objective is to encourage additional investigators to begin work on the structure and function of membrane proteins. Investigators may wish to consider how their work can benefit from or complement the work that is supported through the Roadmap expression centers, the Protein Structure Initiative (PSI) centers and the Specialized PSI centers focusing on membrane proteins (5). An increase in the number of known membrane protein structures will contribute to an enhanced understanding of many basic phenomena underlying cellular functions essential to human health. Specific membrane proteins may be of interest to one or more of the participating Institutes and Centers of the NIH. Rather than listing suggested areas of interest here, potential applicants are encouraged to consider the disease relevance or general interest value of the proteins that they intend to study and to consult with appropriate IC staff regarding IC interest in their projects. See IC Program Contacts below. References: (1) The progress of membrane protein structure determination. Stephen H. White, Protein Science (2004), 13:1948–1949. (2) Structural Biology of Membrane Proteins Program Announcements (PA-95-035, PA-99-004, PA-02-060) and Structural Biology of Membrane Proteins SBIR/STTR Announcement (PA-02-108). See NIH Guide: http://grants.nih.gov/grants/guide/pa-files/. (3) Centers for Innovation in Membrane Protein Production (RFA-RM-04-009). See: http://grants.nih.gov/grants/guide/rfa-files/RFA-RM-04-009.html. See awards at: http://nihroadmap.nih.gov/structuralbiology/fundedresearch.asp (4) Membrane Protein Production and Structure Determination (RFA-RM04-026). See: http://grants.nih.gov/grants/guide/rfa-files/RFA-RM-04-026.html See awards at: http://nihroadmap.nih.gov/structuralbiology/fundedresearch.asp (5) Protein Structure Initiative. See: http://www.nigms.nih.gov/psi/. See Section VIII, Other Information - Required Federal Citations, for policies related to this announcement. Section II. Award Information
1. Mechanism(s) of Support This funding opportunity will use the individual research project grant (R01) award mechanism. As an applicant, you will be solely responsible for planning, directing, and executing the proposed project. This funding opportunity uses just-in-time concepts. It also uses the modular as well as the non-modular budget formats (see http://grants.nih.gov/grants/funding/modular/modular.htm). Specifically, if you are submitting an application with direct costs in each year of $250,000 or less, use the modular budget format described in the PHS 398 application instructions. Otherwise follow the instructions for non-modular research grant applications. 2. Funds Available Because the nature and scope of the proposed research will vary from application to application, it is anticipated that the size and duration of each award will also vary. Although the financial plans of the IC(s) provide support for this program, awards pursuant to this funding opportunity are contingent upon the availability of funds and the receipt of a sufficient number of meritorious applications. Facilities and administrative costs requested by consortium participants are not included in the direct cost limitation; see NOT-OD-05-004. Section III. Eligibility Information 1. Eligible Applicants 1.A. Eligible Institutions You may submit (an) application(s) if your organization has any of the following characteristics: For-profit organizations Non-profit organizations Public or private institutions, such as universities, colleges, hospitals, and laboratories Units of State government Units of local government Eligible agencies of the Federal government Foreign Institutions Domestic Institutions Faith-based or community-based organizations 1. B. Eligible Individuals Any individual with the skills, knowledge, and resources necessary to carry out the proposed research is invited to work with their institution to develop an application for support. Individuals from underrepresented racial and ethnic groups as well as individuals with disabilities are always encouraged to apply for NIH programs. 2. Cost Sharing or Matching This program does not require cost sharing as defined in the current NIH Grants Policy Statement. 3. Other-Special Eligibility Criteria Not applicable
1. Address to Request Application Information The PHS 398 application instructions are available at http://grants.nih.gov/grants/funding/phs398/phs398.html in an interactive format. Applicants must use the currently approved version of the PHS 398. For further assistance contact GrantsInfo, Telephone (301) 435-0714, Email: GrantsInfo@nih.gov. Telecommunications for the hearing impaired: TTY 301-451-5936. 2. Content and Form of Application Submission Applications must be prepared using the most current PHS 398 research grant application instructions and forms. Applications must have a D&B Data Universal Numbering System (DUNS) number as the universal identifier when applying for Federal grants or cooperative agreements. The D&B number can be obtained by calling (866) 705-5711 or through the web site at http://www.dnb.com/us/. The D&B number should be entered on line 11 of the face page of the PHS 398 form. The title and number of this funding opportunity must be typed on line 2 of the face page of the application form and the YES box must be checked. Foreign Organizations Several special provisions apply to applications submitted by foreign organizations: Charge back of customs and import fees is not allowed. Format: every effort should be made to comply with the format specifications, which are based upon a standard US paper size of 8.5" x 11." Funds for up to 8% administrative costs (excluding equipment) can now be requested (http://grants.nih.gov/grants/guide/notice-files/NOT-OD-01-028.html) Organizations must comply with federal/NIH policies on human subjects, animals, and biohazards. Organizations must comply with federal/NIH biosafety and biosecurity regulations. See Section VI. 2. Administrative Requirements, "Cooperative Agreement Terms and Conditions of Award". Proposed research should provide a unique research opportunity not available in the U.S. 3. Submission Dates and Times See Section IV.3.A for details. 3. A. Submission, Review and Anticipated Start Dates Application Receipt Dates(s): Standard dates apply, please see
http://grants.nih.gov/grants/funding/submissionschedule.htm Peer Review Date(s): Standard dates apply; please see http://grants.nih.gov/grants/funding/submissionschedule.htm#reviewandaward for guidance on dates. Council Review Date(s): Standard dates apply; please see http://grants.nih.gov/grants/funding/submissionschedule.htm#reviewandaward for guidance on dates. Earliest Anticipated Start Date: Standard dates apply; please see http://grants.nih.gov/grants/funding/submissionschedule.htm#reviewandaward for guidance on dates. 3. A.1. Letter of Intent A letter of intent is not required for the funding opportunity.
3. B. Sending an Application to the NIH Applications must be prepared using the research grant application forms found in the PHS 398 instructions for preparing a research grant application. Submit a signed, typewritten original of the application, including the checklist, and five signed photocopies in one package to: Center for Scientific Review National Institutes of Health 6701 Rockledge Drive, Room 1040, MSC 7710 Bethesda, MD 20892-7710 (U.S. Postal Service Express or regular mail) Bethesda, MD 20817 (for express/courier service; non-USPS service) Personal deliveries of applications are no longer permitted (see http://grants.nih.gov/grants/guide/notice-files/NOT-OD-03-040.html). 3.C. Application Processing Applications must be submitted on or before the application receipt/submission dates described above (Section IV.3.A.) and at http://grants.nih.gov/grants/dates.htm. Upon receipt applications will be evaluated for completeness by CSR. Incomplete applications will not be reviewed. The NIH will not accept any application in response to this funding opportunity that is essentially the same as one currently pending initial merit review unless the applicant withdraws the pending application. The NIH will not accept any application that is essentially the same as one already reviewed. This does not preclude the submission of a substantial revision of an application already reviewed, but such application must include an Introduction addressing the previous critique. Although there is no immediate acknowledgement of the receipt of an application, applicants are generally notified of the review and funding assignment within eight (8) weeks. 4. Intergovernmental Review This initiative is not subject to intergovernmental review. 5. Funding Restrictions All NIH awards are subject to the terms and conditions, cost principles, and other considerations described in the NIH Grants Policy Statement. The Grants Policy Statement can be found at http://grants.nih.gov/grants/policy/policy.htm. Pre-Award Costs are allowable. A grantee may, at its own risk and without NIH prior approval, incur obligations and expenditures to cover costs up to 90 days before the beginning date of the initial budget period of a new or competing continuation award if such costs: are necessary to conduct the project, and would be allowable under the grant, if awarded, without NIH prior approval. If specific expenditures would otherwise require prior approval, the grantee must obtain NIH approval before incurring the cost. NIH prior approval is required for any costs to be incurred more than 90 days before the beginning date of the initial budget period of a new or competing continuation award. The incurrence of pre-award costs in anticipation of a competing or non-competing award imposes no obligation on NIH either to make the award or to increase the amount of the approved budget if an award is made for less than the amount anticipated and is inadequate to cover the pre-award costs incurred. NIH expects the grantee to be fully aware that pre-award costs result in borrowing against future support and that such borrowing must not impair the grantee's ability to accomplish the project objectives in the approved time frame or in any way adversely affect the conduct of the project. See NIH Grants Policy Statement http://grants.nih.gov/grants/policy/nihgps_2003/NIHGPS_Part6.htm. 6. Other Submission Requirements Specific Instructions for Modular Grant applications. Applications requesting up to $250,000 per year in direct costs must be submitted in a modular budget format. The modular budget format simplifies the preparation of the budget in these applications by limiting the level of budgetary detail. Applicants request direct costs in $25,000 modules. Section C of the research grant application instructions for the PHS 398 at http://grants.nih.gov/grants/funding/phs398/phs398.html includes step-by-step guidance for preparing modular budgets. Applicants must use the currently approved version of the PHS 398. Additional information on modular budgets is available at http://grants.nih.gov/grants/funding/modular/modular.htm. Specific Instructions for Applications Requesting $500,000 (direct costs) or More per Year. Applicants requesting $500,000 or more in direct costs for any year must carry out the following steps: 1) Contact the IC program staff at least 6 weeks before submitting the application, i.e., as you are developing plans for the study; 2) Obtain agreement from the IC staff that the IC will accept your application for consideration for award; and, 3) Include a cover letter with the application that identifies the staff member and IC who agreed to accept assignment of the application. This policy applies to all investigator-initiated new (type 1), competing continuation (type 2), competing supplement, or any amended or revised version of these grant application types. Additional information on this policy is available in the NIH Guide for Grants and Contracts, October 19, 2001 at http://grants.nih.gov/grants/guide/notice-files/NOT-OD-02-004.html. Plan for Sharing Research Data The precise content of the data-sharing plan will vary, depending on the data being collected and how the investigator is planning to share the data. Applicants who are planning to share data may wish to describe briefly the expected schedule for data sharing, the format of the final dataset, the documentation to be provided, whether or not any analytic tools also will be provided, whether or not a data-sharing agreement will be required and, if so, a brief description of such an agreement (including the criteria for deciding who can receive the data and whether or not any conditions will be placed on their use), and the mode of data sharing (e.g., under their own auspices by mailing a disk or posting data on their institutional or personal website, through a data archive or enclave). Investigators choosing to share under their own auspices may wish to enter into a data-sharing agreement. References to data sharing may also be appropriate in other sections of the application. All applicants must include a plan for sharing research data in their application. The data sharing policy is available at http://grants.nih.gov/grants/policy/data_sharing. All investigators responding to this funding opportunity should include a description of how final research data will be shared, or explain why data sharing is not possible. The reasonableness of the data sharing plan or the rationale for not sharing research data will be assessed by the reviewers. However, reviewers will not factor the proposed data sharing plan into the determination of scientific merit or the priority score. Sharing Research Resources NIH policy requires that grant awardee recipients make unique research resources readily available for research purposes to qualified individuals within the scientific community after publication (NIH Grants Policy Statement http://grants.nih.gov/grants/policy/nihgps_2003/index.htm and http://grants.nih.gov/grants/policy/nihgps_2003/NIHGPS_Part7.htm#_Toc54600131). Investigators responding to this funding opportunity should include a plan for sharing research resources addressing how unique research resources will be shared or explain why sharing is not possible. The adequacy of the resources sharing plan and any related data sharing plans will be considered by Program staff of the funding organization when making recommendations about funding applications. The effectiveness of the resource sharing will be evaluated as part of the administrative review of each non-competing Grant Progress Report (PHS 2590, http://grants.nih.gov/grants/funding/2590/2590.htm). See Section VI.3. Reporting. Section V. Application Review Information
1. Criteria Only the review criteria described below will be considered in the review process. 2. Review and Selection Process Applications submitted for this funding opportunity will be assigned to the ICs on the basis of established PHS referral guidelines. Appropriate scientific review groups convened in accordance with the standard NIH peer review procedures (http://www.csr.nih.gov/refrev.htm) will evaluate applications for scientific and technical merit. As part of the initial merit review, all applications will: Undergo a selection process in which only those applications deemed to have the highest scientific merit, generally the top half of applications under review, will be discussed and assigned a priority score. Receive a written critique Receive a second level of review by an appropriate national advisory council or board. The following will be considered in making funding decisions: Scientific merit of the proposed project as determined by peer review Availability of funds Relevance of program priorities The goals of NIH supported research are to advance our understanding of biological systems, to improve the control of disease, and to enhance health. In their written critiques, reviewers will be asked to comment on each of the following criteria in order to judge the likelihood that the proposed research will have a substantial impact on the pursuit of these goals. Each of these criteria will be addressed and considered in assigning the overall score, weighting them as appropriate for each application. Note that an application does not need to be strong in all categories to be judged likely to have major scientific impact and thus deserve a high priority score. For example, an investigator may propose to carry out important work that by its nature is not innovative but is essential to move a field forward. Significance: Does this study address an important problem? If the aims of the application are achieved, how will scientific knowledge or clinical practice be advanced? What will be the effect of these studies on the concepts, methods, technologies, treatments, services, or preventative interventions that drive this field? Approach: Are the conceptual or clinical framework, design, methods, and analyses adequately developed, well integrated, well reasoned, and appropriate to the aims of the project? Does the applicant acknowledge potential problem areas and consider alternative tactics? Innovation: Is the project original and innovative? For example: Does the project challenge existing paradigms or clinical practice; address an innovative hypothesis or critical barrier to progress in the field? Does the project develop or employ novel concepts, approaches, methodologies, tools, or technologies for this area? Investigators: Are the investigators appropriately trained and well suited to carry out this work? Is the work proposed appropriate to the experience level of the principal investigator and other researchers? Does the investigative team bring complementary and integrated expertise to the project (if applicable)? Environment: Does the scientific environment in which the work will be done contribute to the probability of success? Do the proposed studies benefit from unique features of the scientific environment, or subject populations, or employ useful collaborative arrangements? Is there evidence of institutional support? 2.A. Additional Review Criteria: In addition to the above criteria, the following items will continue to be considered in the determination of scientific merit and the priority score: Protection of Human Subjects from Research Risk: The involvement of human subjects and protections from research risk relating to their participation in the proposed research will be assessed (see the Research Plan, Section E on Human Subjects in the PHS Form 398). Inclusion of Women, Minorities and Children in Research: The adequacy of plans to include subjects from both genders, all racial and ethnic groups (and subgroups), and children as appropriate for the scientific goals of the research will be assessed. Plans for the recruitment and retention of subjects will also be evaluated (see the Research Plan, Section E on Human Subjects in the PHS Form 398). Care and Use of Vertebrate Animals in Research: If vertebrate animals are to be used in the project, the five items described under Section F of the PHS Form 398 research grant application instructions will be assessed. Biohazards: If materials or procedures are proposed that are potentially hazardous to research personnel and/or the environment, determine if the proposed protection is adequate. 2.B. Additional Review Considerations Budget: The reasonableness of the proposed budget and the requested period of support in relation to the proposed research. The priority score should not be affected by the evaluation of the budget. 2.C. Sharing Research Data Data Sharing Plan: The reasonableness of the data sharing plan or the rationale for not sharing research data will be assessed by the reviewers. However, reviewers will not factor the proposed data sharing plan into the determination of scientific merit or the priority score. The presence of a data sharing plan will be part of the terms and conditions of the award. The funding organization will be responsible for monitoring the data sharing policy. 2.D. Sharing Research Resources NIH policy requires that grant awardee recipients make unique research resources readily available for research purposes to qualified individuals within the scientific community after publication (See the NIH Grants Policy Statement http://grants.nih.gov/grants/policy/nihgps/part_ii_5.htm#availofrr and http://www.ott.nih.gov/policy/rt_guide_final.html). Investigators responding to this funding opportunity should include a sharing research resources plan addressing how unique research resources will be shared or explain why sharing is not possible. Program staff will be responsible for the administrative review of the plan for sharing research resources. The adequacy of the resources sharing plan will be considered by Program staff of the funding organization when making recommendations about funding applications. Program staff may negotiate modifications of the data and resource sharing plans with the awardee before recommending funding of an application. The final version of the data and resource sharing plans negotiated by both will become a condition of the award of the grant. The effectiveness of the resource sharing will be evaluated as part of the administrative review of each non-competing Grant Progress Report (PHS 2590). See Section VI.3. Reporting. Section VI. Award Administration Information
1. Award Notices If the application is under consideration for funding, NIH will request "just-in-time" information from the applicant. For details, applicants may refer to the NIH Grants Policy Statement Part II: Terms and Conditions of NIH Grant Awards, Subpart A: General (http://grants.nih.gov/grants/policy/nihgps_2003/NIHGPS_part4.htm). A formal notification in the form of a Notice of Award (NoA) will be provided to the applicant organization. The NoA signed by the grants management officer is the authorizing document. Once all administrative and programmatic issues have been resolved, the NoA will be generated via email notification from the awarding component to the grantee business official (designated in item 12 on the Application Face Page). If a grantee is not email enabled, a hard copy of the NoA will be mailed to the business official. Selection of an application for award is not an authorization to begin performance. Any costs incurred before receipt of the NoA are at the recipient's risk. These costs may be reimbursed only to the extent considered allowable pre-award costs. See Also Section IV.5. Funding Restrictions. 2. Administrative and National Policy Requirements All NIH grant and cooperative agreement awards include the NIH Grants Policy Statement as part of the Notice of Award. For these terms of award, see the NIH Grants Policy Statement Part II: Terms and Conditions of NIH Grant Awards, Subpart A: General (http://grants.nih.gov/grants/policy/nihgps_2003/NIHGPS_Part4.htm) and Part II Terms and Conditions of NIH Grant Awards, Subpart B: Terms and Conditions for Specific Types of Grants, Grantees, and Activities (http://grants.nih.gov/grants/policy/nihgps_2003/NIHGPS_part9.htm). 3. Reporting Awardees will be required to submit the PHS Non-Competing Grant Progress Report, Form 2590 annually (http://grants.nih.gov/grants/funding/2590/2590.htm) and financial statements as required in the NIH Grants Policy Statement.
Section VII. Agency Contacts We encourage your inquiries concerning this funding opportunity and welcome the opportunity to answer questions from potential applicants. Inquiries may fall into three areas: scientific/research, peer review, and financial or grants management issues: 1. Scientific/Research Contacts: Peter C. Preusch, Ph.D. Division of Pharmacology, Physiology, and Biological Chemistry National Institute of General Medical Sciences Building 45, 2AS.55E 45 Center Drive , MSC 6200 Bethesda , MD 20892 Telephone: (301) 594-3827 Email: preuschp@nigms.nih.gov
Jean Chin, Ph.D. Division of Cell Biology and Biophysics National Institute of General Medical Sciences Building 45, Room 2AS.19A 45 Center Drive , MSC 6200 Bethesda , MD 20892 Telephone: (301) 594-0828 Email: chinj@nigms.nih.gov
Bradley C. Wise, Ph.D. Neuroscience and Neuropsychology of Aging Program National Institute on Aging Gateway Bldg, Room 350 7201 Wisconsin Ave , MSC 9205 Bethesda , MD 20892 Telephone: (301) 496-9350 Email: wiseb@nia.nih.gov
Glen Nuckolls, Ph.D. Muscle Biology Branch National Institute of Arthritis and Musculoskeletal Diseases One Democracy Plaza , Room 800 6701 Democracy Blvd , MSC 4872 Bethesda , MD 20892 Telephone: (301) 594-4974 Email: gn18s@nih.gov
John R. Knowlton, Ph.D. Structural Biology and Molecular Applications Branch National Cancer Institute Executive Plaza North, Room 5000 6130 Executive Blvd , MSC 7385 Bethesda , MD 20892 Telephone: (301) 435-5226 Email: jk339o@nih.gov
Nancy L. Freeman, PH.D. Hearing and Balance/Vastibular Branch National Institute on Deafness and Other Communication Disorders Executive Plaza South, Room 400 6120 Executive Blvd , MSC 7180 Bethesda , MD 20892 Telephone: (301) 402-3458 Email: freemann@mail.nih.gov
Salvatore Sechi, Ph.D. Division of Diabetes, Endocrinology, and Metabolic Diseases National Institute of Diabetes and Digestive and Kidney Diseases Two Democracy Plaza , Room 611 6707 Democracy Blvd , MSC 5460 Bethesda , MD 20892 Telephone: (301) 594-8814 Email: sechis@extra.niddk.nih.gov
David Balshaw, Ph.D. Center for Risk and Integrated Sciences National Institute of Environmental Health Sciences 4401 Bldg (East Campus), Room 3447 79 TW Alexander Drive Research Triangle Park , NC 27709 Phone: (919) 541-2448 Email: balshaw@niehs.nih.gov
6701 Rockledge Drive , Room 9140, MSC 7940 Bethesda , MD 20892
Chiiko Asanuma, Ph.D. Molecular, Cellular & Genomic Neuroscience Reseaarch Branch National Institute of Mental Health Neuro Science Center , Room 7183 6001 Executive Blvd , MSC 9641 Bethesda , MD 20892 Telephone: (301) 443-5288 Email: cs2j@nih.gov
Randall Stewart, Ph.D. Extramural Research Program National Institute of Neurological Disorders and Stroke Neuro Science Center , Room 2136 6001 Executive Blvd , MSC 9527 Bethesda , MD 20892 Telephone: (301) 496-1917 Email: rs165s@nih.gov
3. Financial or Grants Management Contacts: Grace Olascoaga Grants Management Officer National Institute of General Medical Sciences Building 45, Room 2AN.32C 45 Center Drive , MSC 6200 Bethesda , MD 20892 Telephone: (301) 594-5135 FAX: (301) 480-2554 Email: olascoag@nigms.nih.gov
Linda Whipp Grants Management Officer National Institute on Aging Gateway Bldg, Room 2N212 7201 Wisconsin Ave , MSC 9205 Bethesda , MD 20892 Telephone: (301) 496-1472 Email: whippl@gw.nia.nih.gov
Michael Morse Grants Management Branch National Institute of Arthritis and Musculoskeletal and Skin Diseases One Democracy Plaza , Room 844 6701 Democracy Blvd , MSC 4872 Bethesda , MD 20892 Telephone: (301) 594-3506 FAX: (301) 480-3310 Email: morsem@mail.nih.gov
Leo Buscher Office of Grants Administration National Cancer Institute Executive Plaza South, Room 234 6120 Executive Blvd , MSC 7148 Bethesda , MD 20892 Telephone: (301) 496-7753 Email: buscherel@gab.nci.nih.gov
Christopher P. Myers Grants Management Branch National Institute on Deafness and Other Communication Disorders Executive Plaza South, Room 400B 6120 Executive Blvd , MSC 7180 Bethesda , MD 20892 Telephone: (301) 402-0908 Email: cm143g@nih.gov
David Mineo Grants Management Branch National Institute of Diabetes and Digestive and Kidney Diseases Two Democracy Plaza , Room 731 6707 Democracy Blvd , MSC 5456 Bethesda , MD 20892 Telephone: (301) 594-8854 Email: mineod@extra.niddk.nih.gov
Dorothy G. Duke Grants Management Branch National Institute of Environmental Health Sciences 4401 Bldg (East Campus), Room 3403 79 TW Alexander Dr Research Triangle Park , NC 27709 Telephone: (919) 541-2749 Email: duke3@niehs.nih.gov
6701 Rockledge Drive , Room 7172, MSC 7940 Bethesda , MD 20892
Rebecca Claycamp Grants Management Branch National Institute of Mental Health Neuro Science Center , Room 6122 6001 Executive Blvd , MSC 9605 Bethesda , MD 20892 Telephone: (301) 443-2811 Email: rclaycam@mail.nih.gov
Michael Loewe Grants Management Branch National Institute of Neurological Disorders and Stroke Neuro Science Center , Room 3258 6001 Executive Blvd , MSC 9537 Bethesda , MD 20892 Telephone: (301) 496-9231 Email: ml70m@nih.gov Section VIII. Other Information
Required Federal Citations Use of Animals in Research: Recipients of PHS support for activities involving live, vertebrate animals must comply with PHS Policy on Humane Care and Use of Laboratory Animals (http://grants.nih.gov/grants/olaw/references/PHSPolicyLabAnimals.pdf) as mandated by the Health Research Extension Act of 1985 (http://grants.nih.gov/grants/olaw/references/hrea1985.htm), and the USDA Animal Welfare Regulations (http://www.nal.usda.gov/awic/legislat/usdaleg1.htm) as applicable. Human Subjects Protection: Federal regulations (45CFR46) require that applications and proposals involving human subjects must be evaluated with reference to the risks to the subjects, the adequacy of protection against these risks, the potential benefits of the research to the subjects and others, and the importance of the knowledge gained or to be gained (http://www.hhs.gov/ohrp/humansubjects/guidance/45cfr46.htm). Sharing Research Data: Investigators submitting an NIH application seeking $500,000 or more in direct costs in any single year are expected to include a plan for data sharing or state why this is not possible (http://grants.nih.gov/grants/policy/data_sharing). Investigators should seek guidance from their institutions, on issues related to institutional policies and local IRB rules, as well as local, State and Federal laws and regulations, including the Privacy Rule. Reviewers will consider the data sharing plan but will not factor the plan into the determination of the scientific merit or the priority score. Access to Research Data through the Freedom of Information Act: The Office of Management and Budget (OMB) Circular A-110 has been revised to provide access to research data through the Freedom of Information Act (FOIA) under some circumstances. Data that are (1) first produced in a project that is supported in whole or in part with Federal funds and (2) cited publicly and officially by a Federal agency in support of an action that has the force and effect of law (i.e., a regulation) may be accessed through FOIA. It is important for applicants to understand the basic scope of this amendment. NIH has provided guidance at http://grants.nih.gov/grants/policy/a110/a110_guidance_dec1999.htm. Applicants may wish to place data collected under this funding opportunity in a public archive, which can provide protections for the data and manage the distribution for an indefinite period of time. If so, the application should include a description of the archiving plan in the study design and include information about this in the budget justification section of the application. In addition, applicants should think about how to structure informed consent statements and other human subjects procedures given the potential for wider use of data collected under this award. Sharing of Model Organisms: NIH is committed to support efforts that encourage sharing of important research resources including the sharing of model organisms for biomedical research (see http://grants.nih.gov/grants/policy/model_organism/index.htm). At the same time the NIH recognizes the rights of grantees and contractors to elect and retain title to subject inventions developed with Federal funding pursuant to the Bayh Dole Act (see the NIH Grants Policy Statement http://grants.nih.gov/grants/policy/nihgps_2003/index.htm). All investigators submitting an NIH application or contract proposal, beginning with the October 1, 2004 receipt date, are expected to include in the application/proposal a description of a specific plan for sharing and distributing unique model organism research resources generated using NIH funding or state why such sharing is restricted or not possible. This will permit other researchers to benefit from the resources developed with public funding. The inclusion of a model organism sharing plan is not subject to a cost threshold in any year and is expected to be included in all applications where the development of model organisms is anticipated. Required Education on the Protection of Human Subject Participants: NIH policy requires education on the protection of human subject participants for all investigators submitting NIH applications for research involving human subjects and individuals designated as key personnel. The policy is available at http://grants.nih.gov/grants/guide/notice-files/NOT-OD-00-039.html. Human Embryonic Stem Cells (hESC): Criteria for federal funding of research on hESCs can be found at http://stemcells.nih.gov/index.asp and at http://grants.nih.gov/grants/guide/notice-files/NOT-OD-02-005.html. Only research using hESC lines that are registered in the NIH Human Embryonic Stem Cell Registry will be eligible for Federal funding (http://escr.nih.gov/). It is the responsibility of the applicant to provide in the project description and elsewhere in the application as appropriate, the official NIH identifier(s) for the hESC line(s) to be used in the proposed research. Applications that do not provide this information will be returned without review. NIH Public Access Policy: NIH-funded investigators are requested to submit to the NIH manuscript submission (NIHMS) system (http://www.nihms.nih.gov/) at PubMed Central (PMC) an electronic version of the author's final manuscript upon acceptance for publication, resulting from research supported in whole or in part with direct costs from NIH. The author's final manuscript is defined as the final version accepted for journal publication, and includes all modifications from the publishing peer review process. NIH is requesting that authors submit manuscripts resulting from 1) currently funded NIH research projects or 2) previously supported NIH research projects if they are accepted for publication on or after May 2, 2005. The NIH Public Access Policy applies to all research grant and career development award mechanisms, cooperative agreements, contracts, Institutional and Individual Ruth L. Kirschstein National Research Service Awards, as well as NIH intramural research studies. The Policy applies to peer-reviewed, original research publications that have been supported in whole or in part with direct costs from NIH, but it does not apply to book chapters, editorials, reviews, or conference proceedings. Publications resulting from non-NIH-supported research projects should not be submitted. For more information about the Policy or the submission process please visit the NIH Public Access Policy Web site at http://www.nih.gov/about/publicaccess/ and view the Policy or other Resources and Tools including the Authors' Manual (http://www.nih.gov/about/publicaccess/publicaccess_Manual.htm). Standards for Privacy of Individually Identifiable Health Information: The Department of Health and Human Services (DHHS) issued final modification to the "Standards for Privacy of Individually Identifiable Health Information", the "Privacy Rule", on August 14, 2002. The Privacy Rule is a federal regulation under the Health Insurance Portability and Accountability Act (HIPAA) of 1996 that governs the protection of individually identifiable health information, and is administered and enforced by the DHHS Office for Civil Rights (OCR). Decisions about applicability and implementation of the Privacy Rule reside with the researcher and his/her institution. The OCR website (http://www.hhs.gov/ocr/) provides information on the Privacy Rule, including a complete Regulation Text and a set of decision tools on "Am I a covered entity?" Information on the impact of the HIPAA Privacy Rule on NIH processes involving the review, funding, and progress monitoring of grants, cooperative agreements, and research contracts can be found at http://grants.nih.gov/grants/guide/notice-files/NOT-OD-03-025.html. URLs in NIH Grant Applications or Appendices: All applications and proposals for NIH funding must be self-contained within specified page limitations. Unless otherwise specified in an NIH solicitation, Internet addresses (URLs) should not be used to provide information necessary to the review because reviewers are under no obligation to view the Internet sites. Furthermore, we caution reviewers that their anonymity may be compromised when they directly access an Internet site. Healthy People 2010: The Public Health Service (PHS) is committed to achieving the health promotion and disease prevention objectives of "Healthy People 2010," a PHS-led national activity for setting priority areas. This PA is related to one or more of the priority areas. Potential applicants may obtain a copy of "Healthy People 2010" at http://www.health.gov/healthypeople. Authority and Regulations: This program is described in the Catalog of Federal Domestic Assistance at http://www.cfda.gov/ and is not subject to the intergovernmental review requirements of Executive Order 12372 or Health Systems Agency review. Awards are made under the authorization of Sections 301 and 405 of the Public Health Service Act as amended (42 USC 241 and 284) and under Federal Regulations 42 CFR 52 and 45 CFR Parts 74 and 92. All awards are subject to the terms and conditions, cost principles, and other considerations described in the NIH Grants Policy Statement. The NIH Grants Policy Statement can be found at http://grants.nih.gov/grants/policy/policy.htm. The PHS strongly encourages all grant recipients to provide a smoke-free workplace and discourage the use of all tobacco products. In addition, Public Law 103-227, the Pro-Children Act of 1994, prohibits smoking in certain facilities (or in some cases, any portion of a facility) in which regular or routine education, library, day care, health care, or early childhood development services are provided to children. This is consistent with the PHS mission to protect and advance the physical and mental health of the American people. Loan Repayment Programs: NIH encourages applications for educational loan repayment from qualified health professionals who have made a commitment to pursue a research career involving clinical, pediatric, contraception, infertility, and health disparities related areas. The LRP is an important component of NIH's efforts to recruit and retain the next generation of researchers by providing the means for developing a research career unfettered by the burden of student loan debt. Note that an NIH grant is not required for eligibility and concurrent career award and LRP applications are encouraged. The periods of career award and LRP award may overlap providing the LRP recipient with the required commitment of time and effort, as LRP awardees must commit at least 50% of their time (at least 20 hours per week based on a 40 hour week) for two years to the research. For further information, please see: http://www.lrp.nih.gov/. Weekly TOC for this Announcement